Connect with us

Health

Stanford Study Links Epstein-Barr Virus to Lupus, Revealing Hidden Trigger Behind Autoimmune Disease

Published

on

New research from Stanford University links the Epstein-Barr virus (EBV) to lupus disease, showing how the virus can push immune cells to attack the body’s own tissues. The findings, published this week in Science Translational Medicine, suggest that the common childhood virus may be the key trigger behind lupus, a chronic autoimmune disorder that affects millions worldwide.

According to the study, EBV — a virus carried by more than 90 percent of adults — appears to manipulate the body’s immune cells in a way that sparks lupus. “This is the single most impactful finding to emerge from my lab in my entire career,” said Dr. William Robinson, professor of immunology and rheumatology at Stanford University and the study’s senior author. “We think it applies to 100 per cent of lupus cases.”

Lupus occurs when the immune system mistakenly attacks healthy tissues, leading to inflammation that can damage the skin, joints, kidneys, heart, and nervous system. The disease affects women far more than men, accounting for roughly 90 percent of cases. While medications such as ibuprofen can manage symptoms, about 5 percent of patients develop life-threatening complications. There is currently no cure.

Epstein-Barr virus is best known for causing mononucleosis, or “mono,” often called the “kissing disease.” Most people contract it during childhood or adolescence through saliva, such as by sharing food, drinks, or through kissing. “Practically the only way to not get EBV is to live in a bubble,” Robinson said, noting that the odds of exposure are nearly 20 to 1.

Once inside the body, EBV hides within B cells — immune cells responsible for making antibodies to fight infection. The virus can hijack these cells, turning them rogue and prompting them to attack the body’s own tissues. Researchers found that in lupus patients, EBV-infected B cells are about 25 times more common than in healthy individuals.

See also  Study Links Toddlers’ Gut Health to Later Mental Wellbeing

The virus produces a protein known as EBNA2, which activates human genes linked to inflammation. This triggers an immune chain reaction where B cells stimulate other immune cells to attack cell nuclei, a hallmark of lupus. When enough of these overactive cells accumulate, a full autoimmune response develops.

The study also suggests that the same viral mechanism may contribute to other autoimmune conditions such as multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. Researchers believe that genetics, variations in viral strains, and environmental factors may determine why some individuals develop autoimmune disorders after infection.

Several biotechnology firms are developing vaccines to prevent EBV infection, with early-stage clinical trials already underway. However, experts say such vaccines would only be effective if administered before initial exposure — meaning protection would need to start early in life.

If confirmed, Stanford’s discovery could reshape the understanding of autoimmune diseases and pave the way for preventive strategies against one of the world’s most persistent viruses.

Health

AI Model Surpasses Doctors in Key Medical Decision Tests, Study Finds

Published

on

A new study by researchers at Harvard Medical School and Beth Israel Deaconess Medical Center has found that advanced artificial intelligence systems can outperform human doctors in several medical reasoning tasks, including diagnosis and emergency care decisions.

The research compared physicians with large language models across a range of clinical scenarios. According to the findings, AI systems showed stronger performance in tasks such as identifying likely diagnoses, recommending treatment steps, and making decisions in emergency department settings where information is often limited.

Arjun Manrai, a co-senior author of the study, said the results demonstrate the rapid progress of AI in healthcare. He noted that the model surpassed both earlier systems and physician benchmarks in most tests. At the same time, he cautioned that better performance in controlled settings does not guarantee improved outcomes in real-world care.

The study evaluated OpenAI’s reasoning model, released in 2024, using a mix of published clinical cases and real-world emergency department data. Researchers presented the system with patient scenarios at different stages of care, from initial triage to later admission decisions. At each step, the AI was given only the information available at that point and asked to suggest diagnoses and next actions.

The results showed that the AI consistently outperformed doctors, especially in areas requiring structured reasoning and documentation. The largest gap appeared during the triage stage, when limited information makes decision-making more difficult. As additional data became available, both AI and physicians improved in accuracy, though the AI maintained an edge in many cases.

Peter Brodeur, a co-author of the study, said traditional testing methods such as multiple-choice questions are no longer sufficient to measure progress, as many AI models now achieve near-perfect scores. He added that newer evaluation approaches are needed to track further advances.

See also  U.S. Dominates Global Cancer Research Funding, EU Ramps Up Spending

Despite the promising results, researchers stressed that the use of AI in healthcare must be approached carefully. They warned that while a model may correctly identify a diagnosis, it could also recommend unnecessary tests or interventions that might carry risks for patients.

The study’s authors called for further trials in real clinical environments to better understand how AI tools perform in practice. They also highlighted the need for investment in infrastructure and clear frameworks to support the safe use of such technologies.

The findings come with some limitations, as the analysis focused on a specific version of the AI model, which has since been updated. Researchers said additional studies are needed to compare different systems and explore how doctors and AI can work together effectively in patient care.

Continue Reading

Health

New Study Reveals How Coffee May Help Protect the Body From Ageing

Published

on

A new study has uncovered a key biological mechanism that may explain why coffee has long been linked to healthier ageing and a lower risk of chronic disease.

Researchers at Texas A&M College of Veterinary Medicine & Biomedical Sciences found that compounds in coffee interact with a protein in the body known as NR4A1, a receptor involved in regulating stress responses, inflammation and cellular repair. The findings shed new light on how coffee may help protect the body from age-related decline.

For years, studies have associated regular coffee consumption with a longer life and reduced risk of conditions such as heart disease, cancer and cognitive decline. Until now, however, the biological processes behind those benefits have remained largely unclear.

The research team identified NR4A1 as a critical target for several naturally occurring compounds in coffee, particularly polyphenols and other polyhydroxylated substances. These compounds bind to the receptor and appear to influence how it functions.

NR4A1 acts as what scientists call a nutrient sensor, responding to dietary compounds and helping the body adapt to stress and damage. It plays an important role in controlling inflammation, maintaining energy balance and promoting tissue repair — all essential processes in healthy ageing.

Stephen Safe, one of the study’s lead researchers, said the findings provide a clearer understanding of coffee’s protective effects. He explained that NR4A1 helps limit damage when tissues are under stress, and that its absence can worsen the effects of injury or disease.

Laboratory tests showed that coffee compounds reduced cellular damage and slowed the growth of cancer cells. When researchers removed NR4A1 from the cells, those benefits disappeared, strongly suggesting that the receptor is central to coffee’s protective action.

See also  People in the Northeast Could Prevent a Covid-19 by Following These Measures

The study also highlights that coffee’s health effects are likely driven by more than caffeine alone. Decaffeinated coffee has also been linked to improvements in learning and memory, indicating that other components, including polyphenols, may play a significant role.

Recent research has suggested that moderate consumption of caffeinated coffee may also reduce anxiety, improve attention and vigilance, and lower levels of inflammation.

Scientists caution that while the findings are promising, more research is needed to determine how significant the NR4A1 pathway is in humans and how it interacts with other biological systems.

Still, the discovery offers an important step toward understanding why coffee remains one of the most widely studied beverages in nutrition science. It also reinforces the idea that compounds found in everyday foods and drinks can play a meaningful role in supporting long-term health and resilience as people age.

Continue Reading

Health

Study Finds Rise in 11 Cancers Among Younger Adults in England

Published

on

A major study has found that rates of 11 types of cancer are increasing among younger adults in England, raising fresh concerns among researchers about factors driving the trend.

The study, conducted by the Institute of Cancer Research and Imperial College London, examined cancer diagnoses between 2001 and 2019 in adults aged 20 to 49. It identified rising incidence in a range of cancers, including breast, colorectal, pancreatic and kidney cancers.

The full list includes breast, colorectal, pancreatic, kidney, liver, gallbladder, thyroid, ovarian and endometrial cancers, as well as oral cancer and multiple myeloma, a form of blood cancer.

Researchers noted that for most of these cancers, rates have also increased among older adults, where cancer remains far more common. This suggests that some shared risk factors may be affecting multiple age groups.

Two cancers, however, stood out. Rates of colorectal and ovarian cancer rose only among younger adults, pointing to possible age-specific causes that are not yet fully understood.

Scientists examined a range of established cancer risk factors, including smoking, alcohol consumption, diet, physical activity and body weight. While these factors are known to contribute significantly to cancer risk, they do not appear to fully explain the recent rise in cases among younger people.

In fact, many of these traditional risk factors have either remained stable or improved over recent decades. Smoking rates have declined, alcohol consumption has generally fallen or levelled off, physical inactivity has decreased, and intake of red and processed meat has dropped.

Obesity was the notable exception. Rates of obesity have risen steadily across all adult age groups and remain a significant contributor to cancer risk. Even so, researchers found that obesity alone could not account for the broader increase in cancer diagnoses among younger adults.

See also  US Tariffs on Pharmaceuticals Could Spark Global Trade Disruptions

This was particularly true for cancers commonly associated with excess body weight, such as bowel, kidney, pancreatic, liver, gallbladder and endometrial cancers. While rising obesity may be playing a role, it does not fully explain the trend.

The findings suggest that other factors may be contributing. Researchers say further investigation is urgently needed into possible causes, including environmental exposures, changes in diet or lifestyle during childhood, and other early-life influences.

They also pointed to the possibility that improved diagnostic tools, increased screening and greater public awareness may be leading to more cases being detected.

Public health experts say the study highlights the need for continued prevention efforts, particularly in tackling smoking and obesity, which remain more common in disadvantaged communities. As researchers work to better understand the causes, the rise in cancer among younger adults is likely to remain an important area of focus for health authorities.

Continue Reading

Trending